Patient Handling Demand And North America Trends Will Open Opportunity

Published
03 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
SEK 38.00
13.5% undervalued intrinsic discount
14 Aug
SEK 32.88
Loading
1Y
-19.8%
7D
0.7%

Author's Valuation

SEK 38.0

13.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 9.35%

Shared on23 Apr 25
Fair value Decreased 17%

AnalystConsensusTarget has decreased revenue growth from 3.7% to 2.4% and decreased future PE multiple from 15.0x to 13.1x.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Decreased 3.56%

AnalystConsensusTarget has increased discount rate from 5.3% to 6.4%.